You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BCLC0 or A

Showing 1 - 25 of 125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-term Effects of Cancer Treatment Trial in Wuhan (liver resection)

Completed
  • Long-term Effects of Cancer Treatment
  • liver resection
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Nov 10, 2021

Resectable Hepatocellular Carcinoma Trial in Jakarta Pusat (Liver Resection)

Completed
  • Resectable Hepatocellular Carcinoma
  • Liver Resection
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Dr. Cipto Mangunkusumo General Hospital
Aug 24, 2023

Hepatocellular Carcinoma by BCLC Stage Trial in Guangzhou (Bevacizumab Biosimilar QL 1101)

Not yet recruiting
  • Hepatocellular Carcinoma by BCLC Stage
  • Bevacizumab Biosimilar QL 1101
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 20, 2023

Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial (Liquid Biopsy)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Liquid Biopsy
  • (no location specified)
Apr 18, 2023

Advanced Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Hepatocellular Carcinoma, Liver Cancer, Cirrhosis Trial in Bondy (Liver ultrasound and fast-MRI, Liver ultrasound)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Liver ultrasound and fast-MRI
  • Liver ultrasound
  • Bondy, France
    Assistance Publique Hôpitaux de Paris - Hôpital Avicenne
Oct 22, 2021

Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • +3 more
  • Resin microspheres containing yttrium-90 (Y-90)
  • Mission Hills, California
  • +15 more
Sep 15, 2022

Non Transplantable Recurrence After Percutaneous Thermal

Completed
  • HCC
  • Percutaneous thermal ablation
  • Montpellier, France
    Uhmontpellier
Jan 24, 2022

Proteome Multimarker Panel With Multiple Reaction Monitoring

Not yet recruiting
  • Liver Cirrhosis
  • multiple reaction monitoring (MRM)-based multimarker panel
  • (no location specified)
Mar 5, 2023

HVPG and ICG-R15 in Short- and Medium-term Results of Surgery of

Recruiting
  • Hepatocellular Carcinoma
  • Hepatic venous-portal gradient (HVPG) measurement
  • Napoli, Italy
    Federico II University Hospital
Mar 24, 2023

BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in

Recruiting
  • BCLC Stage A Hepatocellular Carcinoma
  • +3 more
  • 18F-Fluoromisonidazole
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
May 25, 2022

Hepatocellular Carcinoma Trial (The neutrophil-to- lymphocyte ratio, Prognostic nutrition index)

Not yet recruiting
  • Hepatocellular Carcinoma
  • The neutrophil-to- lymphocyte ratio
  • Prognostic nutrition index
  • (no location specified)
Jul 28, 2023

Radiomics, Hepatocellular Carcinoma (HCC), Transcatheter Arterial Chemoembolization (TACE) Trial in Guangzhou (Sorafenib,

Active, not recruiting
  • Radiomics
  • +4 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jun 5, 2023

C-staged Hepatocellular Carcinoma in BCLC Classification Trial in Guangzhou, Guanzhou, Changsha (Hepatic Arterial Infusion

Recruiting
  • C-staged Hepatocellular Carcinoma in BCLC Classification
  • Hepatic Arterial Infusion combined with Apatinib and Camrelizumab
  • Apatinib combined with Camrelizumab
  • Guangzhou, Guangdong, China
  • +4 more
Jun 15, 2022

Liver Cirrhosis, Hepatocellular Carcinoma Trial (Elecsys® GAAD)

Not yet recruiting
  • Liver Cirrhosis
  • Hepatocellular Carcinoma
  • Elecsys® GAAD
  • (no location specified)
Aug 4, 2023

Hepatocellular Carcinoma Trial in Brussels (Radioembolization using Holmium-166)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Radioembolization using Holmium-166
  • Brussels, Anderlecht, Belgium
    Hôpital Universitaire Erasme, ULB
Dec 7, 2022

Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, sintilimab plus SIRT)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Lenvatinib, sintilimab plus SIRT
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 8, 2023

C-staged Hepatocellular Carcinoma in BCLC Classification Trial in Guangzhou (Hepatic Arterial Infusion combined with Apatinib

Recruiting
  • C-staged Hepatocellular Carcinoma in BCLC Classification
  • Hepatic Arterial Infusion combined with Apatinib and Camrelizumab
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 3, 2022

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • BCLC Stage B Hepatocellular Carcinoma
  • +9 more
  • Durvalumab
  • Tremelimumab
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (Sin-Bev-TACE, Len-TACE)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Aug 2, 2023

Unresectable Hepatocellular Carcinoma, Hepatocellular Carcinoma by BCLC Stage Trial in Guangzhou, Guanzhou, Changsha (Hepatic

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Hepatocellular Carcinoma by BCLC Stage
  • Hepatic Arterial Infusion(mFOLFOX7) combined with Bevacizumab and Sintilimab
  • Guangzhou, Guangdong, China
  • +4 more
May 4, 2022

Hepatocellular Carcinoma Trial in Wuhan (HAIC, Sintilimab, Bevacizumab Biosimilar IBI305)

Recruiting
  • Hepatocellular Carcinoma
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Nov 8, 2022

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Not yet recruiting
  • BCLC Stage B Hepatocellular Carcinoma
  • +10 more
  • Ipilimumab
  • Nivolumab
  • Miami, Florida
  • +4 more
Aug 23, 2022

Hepatocellular Carcinoma Trial in Guangzhou (TACE/HAIC, Lenvatinib, Sintilimab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • TACE/HAIC
  • +3 more
  • Guangzhou, Guangdong, China
    Third Affiliated Hospital, Sun Yat-Sen University
Feb 15, 2022

Hepatocellular Carcinoma Trial in Dhaka (Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Dhaka, Bangladesh
  • +1 more
May 21, 2022